Novel cyclodextrin-based film formulation intended for buccal delivery of atenolol Cyclodextrin-based film formulation for buccal delivery of atenolol

Drug Development and Industrial Pharmacy

Volumn 35, Issue 7, 2009, Pages 796-807

  Jug, M ^a   Becirevic Lacan, M ^a   Bengez, S ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Atenolol; Bioadhesion; Buccal delivery; Polymeric films; Randomly methylated cyclodextrin

Indexed keywords

ATENOLOL; BETA CYCLODEXTRIN; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; POLYVINYL ALCOHOL; RANDOMLY METHYLATED BETA CYCLODEXTRIN; UNCLASSIFIED DRUG;

ADHESION; ARTICLE; BUCCAL DRUG ADMINISTRATION; CHEEK MUCOSA; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; DRUG SOLUBILITY; FILM COATING; FREEZE DRYING; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; POLYMERIZATION; SOLID STATE; SOLUBILITY; STOICHIOMETRY;

ADHESIVENESS; ADMINISTRATION, BUCCAL; ATENOLOL; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; DRUG DELIVERY SYSTEMS;

EID: 70350630424     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802596212     Document Type: Article

References (30)

1. Hoffman BB. (2001). Catecholamines, sympatomimetics drug and adrenergic receptor antagonists. In: Hardman JG, Limbid LE, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed. New York, NY: McGraw Hill, 235-238
2. Brown HC, Carruthers MD, Johnston GD. (1976). Clinical pharmacologic observations on atenolol, a β-adrenoreceptor blocker. Clin Pharmacol Ther, 20:524-534
3. Sastry SV, Reddy IK, Kahn MA. (1997). Atenolol gastrointestinal therapeutic system: Optimization of formulation variables using response surface methodology. J Control Release, 45:121-130
4. Cho CW, Shin SC. (2004). Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix. Int J Pharm, 287:67-71.
5. Hao J, Heng PWS. (2003). Buccal delivery systems. Drug Del Ind Pharm, 29:821-832
6. Sudhakar Y, Koutsu K, Bandyopadhyay AK. (2006). Buccal bioadhesive drug delivery-a promising option for orally less efficient drugs. J Control Release, 114:15-40.
7. Salamat-Miller N, Chittchang M, Johnston TP. (2005). The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Del Rev, 57:1666-1691
8. Davis ME, Brewster ME. (2004). Cyclodextrin based Pharmaceutics: Past, Present and future. Nat Rev Drug Discovery, 3:1023-1035
9. Marttin E, Verhoef JC, Spies F, van der Meulen J, Nagelkerke JF, Koerten HK, et al. (1999). The effect of methylated β-cyclodextrins on the tight junctions of the rat nasal respiratory epithelium: Electron microscopic and confocal laser scanning microscopic visualization studies. J Control Release, 57:205-213
10. Masson M, Loftsson T, Masson G, Stefansson E. (1999). Cyclodextrins as permeation enhancers: Some theoretical evaluation and in vivo testing. J Control Release, 59:107-118
11. Merkus FWHM, Verhoef JC, Marttin E, Romejin SG, van der Kuy PHM, Hermens WAJJ, et al. (1999). Cyclodextrins in nasal drug delivery. Adv Drug Del Rev, 36:41-57.
12. Bouldmedarat L, Bochot A, Lesieur S, Fattal E. (2005). Evaluation of buccal methyl-β-cyclodextrin toxicity on human oral epithelial cell culture model. J Pharm Sci, 94:1300-1309
13. Verma N, Wahi AK, Verma A, Chattopadhayay P. (2007). Evaluation of a mucoadhesive buccal patch for delivery of atenolol: In vitro screening of bioadhesion. JPAM, 1:115-118
14. Satishbabu B, Srinivasan B. (2008). Preparation and evaluation of buccoadhesive films of atenolol. Ind J Pharm Sci, 70:175-179
15. Higuchi T, Connors K. (1965). Phase solubility techniques. Adv Anal Chem Instrum, 7:117-212.
16. Loftsson T, Masson M, Sigurjonsdottir JF. (1999). Method to enhance the complexation efficiency of cyclodextrin. STP Pharma Sci, 9:237-242
17. Mura P, Zerrouk N, Faucci MT, Maestrelli F, Chemtob C. (2002). Comparative study of ibuproxam complexation with amorphous β-cyclodextrin derivates in solution and in solid state. Eur J Pharm Biopharm, 54:181-191
18. Brown ME, Glass BD, Worthington MS. (2002). Binary systems of nifedipine and various cyclodextrins in the solid state: Thermal, FTIR XRD studies. J Therm Anal Calorim, 68:631-646
19. Morita R, Honda R, Takashashi Y. (2000). Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS). I. Design of SVRS and its release controlling factor. J Control Release, 63:297-304.
20. Kavanagh N, Corrigan OI. (2004). Swelling and erosion properties of hydroxypropyl methylcellulose (Hypromelose) matrices-influence of agitation rate and dissolution medium composition. Int J Pharm, 279:141-152
21. Jacques Y, Bruni P. (1997). An investigation of the physical behaviour of moisture activated hydrogels upon contact with biological and nonbiological substrates. Pharm Acta Helv, 72:225-232
22. Soppimath KS, Kulkarni AR, Aminabhavi TM. (2001). Chemically modified polyacrylamide-g-guar gum-based crosslinked anionic microgels as pH-sensitive drug delivery systems: Preparation and characterization. J Control Release, 75:331-345
23. Tobyn MA, Johnson JR, Dettmar PW. (1997). Factors affecting in vitro gastric mucoadhesion. IV. Influence of tablet excipients, surfactants and salts on the observed mucoadhesion of polymers. Eur J Pharm Biopharm, 43:65-71.
24. Loftsson T, Masson M. (2004). The effect of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs. J Drug Del Sci Tech, 14:35-43.
25. Azarmi S, Roa W, Löbenberg R. (2007). Current perspectives in dissolution testing of conventional and novel dosage forms. Int J Pharm, 328:12-21.
26. Han RY, Fang JY, Sung KC, Hu OYP. (1999). Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: Effect of formulation variables on drug release and mucoadhesive properties. Int J Pharm, 177:201-209
27. Douroumis D, Fahr A. (2007). Stabile carbamazepine colloidal systems using the cosolvent technique. Eur J Pharm Sci, 30:367-374
28. Khougaz K, Clas SD. (2000). Crystallization inhibition in solid dispersions of MK-0591 and polyvinylpyrrolidone polymers. J Pharm Sci, 89:1325-1334
29. Raghavan SL, Trividic A, Davis AF, Hadgraft J. (2001). Crystallization of hydrocortisone acetate: Influence of polymers. Int Pharm, 212:213-221
30. Bibby DC, Davies NM, Tucker IG. (2000). Mechanism by which cyclodextrins modify drug release from polymeric drug delivery systems. Int J Pharm, 197:1-11.